204 related articles for article (PubMed ID: 11874898)
1. Opsonophagocytosis of fluorescent polystyrene beads coupled to Neisseria meningitidis serogroup A, C, Y, or W135 polysaccharide correlates with serum bactericidal activity.
Martinez J; Pilishvili T; Barnard S; Caba J; Spear W; Romero-Steiner S; Carlone GM
Clin Diagn Lab Immunol; 2002 Mar; 9(2):485-8. PubMed ID: 11874898
[TBL] [Abstract][Full Text] [Related]
2. Assignment of Neisseria meningitidis serogroups A, C, W135, and Y anticapsular total immunoglobulin G (IgG), IgG1, and IgG2 concentrations to reference sera.
Joseph H; Balmer P; Bybel M; Papa T; Ryall R; Borrow R
Clin Diagn Lab Immunol; 2004 Jan; 11(1):1-5. PubMed ID: 14715537
[TBL] [Abstract][Full Text] [Related]
3. Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group.
Maslanka SE; Gheesling LL; Libutti DE; Donaldson KB; Harakeh HS; Dykes JK; Arhin FF; Devi SJ; Frasch CE; Huang JC; Kriz-Kuzemenska P; Lemmon RD; Lorange M; Peeters CC; Quataert S; Tai JY; Carlone GM
Clin Diagn Lab Immunol; 1997 Mar; 4(2):156-67. PubMed ID: 9067649
[TBL] [Abstract][Full Text] [Related]
4. Development and evaluation of a tetraplex flow cytometric assay for quantitation of serum antibodies to Neisseria meningitidis serogroups A, C, Y, and W-135.
Lal G; Balmer P; Joseph H; Dawson M; Borrow R
Clin Diagn Lab Immunol; 2004 Mar; 11(2):272-9. PubMed ID: 15013975
[TBL] [Abstract][Full Text] [Related]
5. Meningococcal Serogroup A, B, C, W, X, and Y Serum Bactericidal Antibody Assays.
Lucidarme J; Louth J; Townsend-Payne K; Borrow R
Methods Mol Biol; 2019; 1969():169-179. PubMed ID: 30877677
[TBL] [Abstract][Full Text] [Related]
6. Safety and immunogenicity of a serogroups A/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children. A randomized controlled trial.
Lieberman JM; Chiu SS; Wong VK; Partidge S; Chang SJ; Chiu CY; Gheesling LL; Carlone GM; Ward JI
JAMA; 1996 May; 275(19):1499-503. PubMed ID: 8622225
[TBL] [Abstract][Full Text] [Related]
7. Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine.
Robertson CA; Greenberg DP; Hedrick J; Pichichero M; Decker MD; Saunders M
Vaccine; 2016 Oct; 34(44):5273-5278. PubMed ID: 27642132
[TBL] [Abstract][Full Text] [Related]
8. Preclinical immunogenicity and functional activity studies of an A+W meningococcal outer membrane vesicle (OMV) vaccine and comparisons with existing meningococcal conjugate- and polysaccharide vaccines.
Tunheim G; Arnemo M; Næss LM; Fjeldheim ÅK; Nome L; Bolstad K; Aase A; Mandiarote A; González H; González D; García L; Cardoso D; Norheim G; Rosenqvist E
Vaccine; 2013 Dec; 31(51):6097-106. PubMed ID: 24120679
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis Serogroups A, C, Y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United Kingdom.
Blanchard-Rohner G; Snape MD; Kelly DF; O'Connor D; John T; Kibwana E; Parks H; Ford K; Dull PM; Pollard AJ
Pediatr Infect Dis J; 2013 Jul; 32(7):768-76. PubMed ID: 23538521
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of Antibody-Mediated, Complement-Dependent Opsonophagocytic Activity against Neisseria meningitidis Serogroup B in England.
Humphries HE; Brookes C; Allen L; Kuisma E; Gorringe A; Taylor S
Clin Vaccine Immunol; 2015 May; 22(5):503-9. PubMed ID: 25739917
[TBL] [Abstract][Full Text] [Related]
11. Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005.
Ceyhan M; Yildirim I; Balmer P; Riley C; Laher G; Andrews N; Borrow R; Kurt N; Turgut M; Aydogan A; Ecevit C; Uysal G; Schultze V
Vaccine; 2007 Oct; 25(41):7233-7. PubMed ID: 17707957
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and safety of the quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in splenectomized or hyposplenic children and adolescents: Results of a phase III, open, non-randomized study.
Klein NP; Habanec T; Kosina P; Shah NR; Kolhe D; Miller JM; Hezareh M; Van der Wielen M
Vaccine; 2018 Apr; 36(17):2356-2363. PubMed ID: 29576307
[TBL] [Abstract][Full Text] [Related]
13. Functional opsonic activity of human serum antibodies to inner core lipopolysaccharide (galE) of serogroup B meningococci measured by flow cytometry.
Plested JS; Ferry BL; Coull PA; Makepeace K; Lehmann AK; MacKinnon FG; Griffiths HG; Herbert MA; Richards JC; Moxon ER
Infect Immun; 2001 May; 69(5):3203-13. PubMed ID: 11292742
[TBL] [Abstract][Full Text] [Related]
14. Low immunogenicity of quadrivalent meningococcal vaccines in solid organ transplant recipients.
Wyplosz B; Derradji O; Hong E; François H; Durrbach A; Duclos-Vallée JC; Samuel D; Escaut L; Launay O; Vittecoq D; Taha MK
Transpl Infect Dis; 2015 Apr; 17(2):322-7. PubMed ID: 25645691
[TBL] [Abstract][Full Text] [Related]
15. Serum factors and polymorphonuclear leukocytes in human host defence against Neisseria meningitidis. Studies of interactions with special reference to a chemiluminometric technique.
Fredlund H
Scand J Infect Dis Suppl; 1993; 87():1-72. PubMed ID: 8511525
[TBL] [Abstract][Full Text] [Related]
16. Serological specificities of murine hybridoma monoclonal antibodies against Neisseria meningitidis serogroups B, C, Y, and W135 and evaluation of their usefulness as serogrouping reagents by indirect whole-cell enzyme-linked immunosorbent assay.
Tsang RS; Zollinger WD
Clin Diagn Lab Immunol; 2005 Jan; 12(1):152-6. PubMed ID: 15643000
[TBL] [Abstract][Full Text] [Related]
17. Adolescent meningococcal serogroup A, W and Y immune responses following immunization with quadrivalent meningococcal A, C, W and Y conjugate vaccine: Optimal age for vaccination.
van Ravenhorst MB; van der Klis FRM; van Rooijen DM; Sanders EAM; Berbers GAM
Vaccine; 2017 Aug; 35(36):4753-4760. PubMed ID: 28647167
[TBL] [Abstract][Full Text] [Related]
18. Development of a multiplexed fluorescent immunoassay for the quantitation of antibody responses to four Neisseria meningitidis serogroups.
Martins TB; Jaskowski TD; Tebo A; Hill HR
J Immunol Methods; 2009 Mar; 342(1-2):98-105. PubMed ID: 19159627
[TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of a rapid multianalyte particle-based flow cytometric assay for the quantification of meningococcal serogroup B-specific IgM antibodies in sera for nonculture case confirmation.
Laher G; Balmer P; Gray SJ; Dawson M; Kaczmarski EB; Borrow R
FEMS Immunol Med Microbiol; 2006 Oct; 48(1):34-43. PubMed ID: 16965350
[TBL] [Abstract][Full Text] [Related]
20. Persistence of antibodies for 42 months following vaccination of adolescents with a meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine (MenACWY-TT).
Østergaard L; Van der Wielen M; Bianco V; Miller JM
Int J Infect Dis; 2013 Mar; 17(3):e173-6. PubMed ID: 23246368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
